Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: A 2 year observational study

Psychopharmacology Bulletin

Volumn 43, Issue 2, 2010, Pages 67-81

  Nyakyoma, Kazare ^a   Morriss, Richard ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Antipsychotic agents; Hospital readmission; Patient readmission; Schizoaffective disorder; Schizophrenia

Indexed keywords

AMISULPRIDE; CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL DECANOATE; FLUPHENAZINE; HALOPERIDOL; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT; OLANZAPINE; PIPOTIAZINE PALMITATE; QUETIAPINE; RISPERIDONE; SULPIRIDE; ZUCLOPENTHIXOL ACETATE;

ADULT; AGRANULOCYTOSIS; ARTICLE; CLINICAL PRACTICE; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; NEUTROPENIA; OBSERVATIONAL STUDY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; CLOZAPINE; COHORT STUDIES; DRUG RESISTANCE; ENGLAND; FEMALE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; ODDS RATIO; PATIENT DISCHARGE; PROPORTIONAL HAZARDS MODELS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952977491     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. World Health Report. Mental Health: New Understanding, New Hope. Geneva: World Health Organisation; 2001.
2. Weiden P, Aquila R, Standard J. Atypical antipsychotic drugs and long-term outcome in schizophrenia. J Clin Psychiatry. 1996;57(Suppl 11):53-60. (Pubitemid 26389786)
3. Robinson D, Woerner MG, Alvir JMJ, Bilder RM, Lencz T, Ashtari M, Wu H, Bogerts B. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999;56:241-247. (Pubitemid 29125132)
4. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine in treatment-resistant schizophrenics. Psychopharmacol Bull. 1988;24:62-67.
5. Lewis SW, Barnes TRE, Davies L. Randomised controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull. 2006;32:715-723. (Pubitemid 44412859)
6. Leucht S, Barnes T, Kissling W, Engel R, Correll C, Kane J. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry. 2003;160:1209-1222. (Pubitemid 41070936)
7. Essock S, Hargreaves W, Covell N, Goethe J. Clozapine's effectiveness for patients in state hospitals: results from a randomized trial. Psychopharmacol Bull. 1996;32:683-697. (Pubitemid 26428274)
8. Tiihonen J, Wahlbeck K, Lonnqvist J, Klaukka T, Ioannidis JP, Volavka J, Haukka J. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ. 2006;333:224-227. (Pubitemid 44406713)
9. Pollack S, Woerner M, Howard A, Fireworker RB, Kane JM. Clozapine reduces rehospitalisation among schizophrenia patients. Psychopharmacol Bull. 1998;34:89-92. (Pubitemid 28176307)
10. Conley R, Kelly D, Love R, McMahon RP. Rehospitalization risk with second generation and depot antipsychotics. Ann Clin Psychiatry. 2003;15:23-31. (Pubitemid 36723638)
11. Lin CH, Lin SC, Chen MC, Wang SY. Comparison of time to rehospitalization among schizophrenic patients discharged on typical antipsychotics, clozapine or risperidone. J Chin Med Assoc. 2006;69:264-269.
12. Werneck de Castro AP, Elkis H. Rehospitalization rates of patients with schizophrenia discharged on haloperidol, risperidone or clozapine. Rev Bras Psiquiatr. 2007;29:207-212.
13. Herceg M, Jukic V, Vidovic D, Erdeljic V, Celic I, Kozumplik O, Bagaric D, Silobrcic Radic M. Two-year rehospitalization rates of patients with newly diagnosed or chronic schizophrenia on atypical or typical antipsychotic drugs: retrospective cohort study. Croat Med J. 2008;49:215-223. (Pubitemid 351669462)
14. National Institute for Health and Clinical Excellence: Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care. London: NICE; 2002 (Clinical guideline no. 1).
15. National Institute for Health and Clinical Excellence: Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care (update). London: NICE; 2009 (Clinical guideline no. 82).
16. Roick C, Heider D, Killian R, Matschinger H, Toumi M, Angermeyer MC. Factors contributing to frequent use of psychiatric inpatient services by schizophrenia patients. Soc Psychiatry Psychiatr Epidemiol. 2004;39:744-751. (Pubitemid 39369179)
17. Sullivan G, Wells K, Morgenstern H, Leake B. Identifying modifiable risk factors for rehospitalisation: a case-control study of seriously mentally ill persons in Mississippi. Am J Psychiatry. 1995;152:1749-1756.
18. O'Brien A, Firn M. Clozapine initiation in the community. Psychiatr Bull R Coll Psychiatr. 2002;26:339-341. (Pubitemid 34987677)
19. Aitchson KJ, Kerwin RW. Cost effectiveness of clozapine. Br J Psychiatry. 1997;171:125-130.
20. Ghaemi SN, Ziegler DM, Peachey TJ, Goodwin FK. Cost-effectiveness of clozapine therapy for severe psychosis. Psychiatr Serv. 1998;49:829-831. (Pubitemid 28274636)
21. Hayhurst KP, Brown P, Lewis SW. The cost-effectiveness of clozapine: a controlled, population-based, mirror-image study. J Psychopharmacol. 2002;16:169-175. (Pubitemid 34614887)
22. Avnon M, Rabinowitz J. Effectiveness of clozapine in hospitalised people with chronic neurolepticresistant schizophrenia. Br J Psychiatry. 1995;167:760-764. (Pubitemid 26197792)
23. Sernyak MJ, Rosenheck R, Desai R, Stolar M, Ripper G. Impact of clozapine prescription on inpatient resource utilization. J Nerv Ment Dis. 2001;189:766-773. (Pubitemid 33095526)
24. Onyon R, Khan S, George M. Delayed discharges from a psychiatric intensive care unit-are we detaining patients unlawfully? J Psychiatr Intensive Care. 2006;2:59-64.
25. Woodall A, Menkes D, Trevelyan T, Lanceley CP. A study of clozapine and long-term hospitalisation rates. Psychiatr Bull R Coll Psychiatr. 2004;28:285-288. (Pubitemid 39144914)
26. Conley RR, Carpenter WT Jr, Tamminga CA. Time to clozapine response in a standardized trial. Am J Psychiatry. 1997;154:1243-1247. (Pubitemid 27369175)
27. Still J, Dorson P, Crismon M, Pousson C. Effects of switching inpatients with treatment resistant schizophrenia from clozapine to risperidone. Psychiatr Serv. 1996;47:1382-1384. (Pubitemid 26406077)
28. Shiovitz TM, Welke TL, Tigel PD, Anand R, Hartman RD, Sramek JJ, Kurtz NM, Cutler NR. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophr Bull. 1996;22:591-595. (Pubitemid 26389405)
29. Wheeler AJ. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Ann Pharmacother. 2008;42:852-860. (Pubitemid 351778093)